Page last updated: 2024-10-30

labetalol and Angioma

labetalol has been researched along with Angioma in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montolivo, M1
Gemma, M1
Regi, B1
Coffano, B1
Giannini, A1
Grandi, L1
Fiacchino, F1

Other Studies

1 other study available for labetalol and Angioma

ArticleYear
Labetalol as prophylaxis of cardiovascular instability after cerebral angioma surgery.
    Minerva anestesiologica, 1993, Volume: 59, Issue:12

    Topics: Brain Neoplasms; Epinephrine; Hemangioma; Humans; Hypertension; Labetalol; Norepinephrine; Postopera

1993